These companies saw their stocks spike after impressively beating earnings expectations last week and more upside could be ahead considering EPS estimates for fiscal 2024 have trended higher afterwards.
ResMed (RMD) could produce exceptional returns because of its solid growth attributes.
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.